Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -2.0% | -13.1% | 0 / 3 | +7.2% | -3.41 pp | -2.14 pp | +11.7% | 0.14 | 7.74 | 71,6 | +7,2% | 16,3 | −2,0% | 7.74 | 8.96 | −13,6% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 1.809
Financial charts
1.Revenue & growth
VND bn71,6Q2/26
1.Revenue & growth
VND bn71,6Q2/26
2.Profit & growth
VND bn16,3Q2/26
3.Profit mix (Penman)
VND bn64,4Q2/26
4.Margins & cost structure
%64.7%Q2/26
5.Returns & cash cycle
% · days11.9%Q2/26
6.Earnings quality & cash
VND bn84,8Q2/26
7.Asset structure
VND bn556Q2/26
8.Funding & debt health
VND bn · times556Q2/26
9.Revenue backlog
VND bn0,15Q2/26
10.Valuation
times · %7,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %556Q2/26
Adjusted EPS growth, latest quarter
-2.0%
Average adjusted EPS growth, 3 quarters
-13.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26